Anbio Biotechnology
NNNN
Last
$4.66
Day
+0.9%
1y
-84.4%
5y
-19.9%
52w
-89.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
5.73
EMA 50
7.60
EMA 200
16.36
20d high
-33.5%
5y high
-91.7%
5y range
0th
Positions held
Your positionsNNNN isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-27
Hold
avoid
Signal
Strong Sell
Target
$5.57
Stop
$3.83
Stop distance
17.8%
Target vs last
+19.5%
Fundamentals
| Market cap | $202.78M | Enterprise value | $190.88M | Trailing P/E | 30.80 | Forward P/E | — |
| PEG | — | Price / book | 6.72 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 73.9% | Earnings growth | — | Gross margin | 87.2% | Operating margin | 59.1% |
| Profit margin | 74.1% | ROE | 27.0% | ROA | 14.7% | Debt / equity | — |
| Current ratio | 344.31 | Free cash flow | -$9.61M | Analyst recommendation | none | Mean target | — |
| 52w high | $44.73 | 52w low | $4.55 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $8.6M | $8.2M | $6.7M | $23.5M | — |
| Op margin | 66.7% | 24.4% | 29.2% | 43.3% | — |
| Net income | $6.4M | $2.4M | $2.3M | $10.0M | — |
| Gross margin | 87.2% | 71.9% | 50.1% | 53.4% | — |
| Gross profit | $7.5M | $5.9M | $3.4M | $12.6M | — |
| Operating income | $5.8M | $2.0M | $2.0M | $10.2M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsNNNN · daily-17.2% over 13 sessions
Close EMA21 EMA50 EMA200